Location: Canada, British Columbia, Vancouver
Employees: 11-50
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Synaptic V... | synaptic.v... |
Mentions in press and media 14
| Date | Title | Description |
| 04.12.2021 | Entheon Biomedical Announces Participation in the Benzinga Global Small Cap Conference | Detroit, Michigan--(Newsfile Corp. - December 3, 2021) - Entheon Biomedical (CSE: ENBI) will be presenting at the Benzinga Global Small Cap Conference taking place on December 8-9, 2021. We invite our shareholders and all interested parties... |
| 25.08.2021 | Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon Advisory Board | Vancouver, British Columbia--(Newsfile Corp. - August 25, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic me... |
| 24.08.2021 | Entheon Biomedical Corp. Announces DTC Eligibility | Vancouver, British Columbia--(Newsfile Corp. - August 24, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic me... |
| 12.08.2021 | Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine | Vancouver, British Columbia--(Newsfile Corp. - August 12, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic me... |
| 28.07.2021 | Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw | Vancouver, British Columbia--(Newsfile Corp. - July 28, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medi... |
| 30.06.2021 | Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana | Vancouver, British Columbia--(Newsfile Corp. - June 30, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medi... |
| 22.06.2021 | Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave | Vancouver, British Columbia--(Newsfile Corp. - June 22, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medi... |
| 17.06.2021 | ENTHEON BIOMEDICAL CORP. Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences and Silo Wellness Announces Psychedelics Genetic Test Kit Partnership | Vancouver, British Columbia--(Newsfile Corp. - June 17, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon"), a biotechnology company focused on developing psychedelic medicines to treat addiction, a... |
| 16.06.2021 | ENTHEON BIOMEDICAL CORP. Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc. | Vancouver, British Columbia--(Newsfile Corp. - June 16, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company") is pleased to announce that the Company has entered into a defi... |
| 18.05.2021 | ENTHEON BIOMEDICAL CORP. Entheon Biomedical Announces DMT Drug Supply Agreement with Ofichem Group | Vancouver, British Columbia--(Newsfile Corp. - May 18, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medic... |
Show more